MSN Laboratories Private Limited

MSN Laboratories Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24239TG2003PTC041583 Incorporated 27 August 2003 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Revenue · FY 2025
₹7,562.77 Cr
▲ 12% YoY
Net profit · FY 2025
₹633.1 Cr
Net margin 8.4%
EBITDA · FY 2025
₹1,500.91 Cr
EBITDA margin 19.8%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹5.2 Cr
Issued & subscribed
Open charges
₹7,446.49 Cr
Satisfied ₹610.63 Cr
Company age
23 yrs
Est. 2003
Employees · EPFO
12,398
Provident fund records

About MSN Laboratories Private Limited

Data last updated:

MSN Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 August 2003 and has been in existence for over 23 years.

Its director M Satyanarayana Reddy and family are #169 among India's richest people (2026). Its director Chintapally Bharat Reddy and family are #641 among India's richest people (2026).

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2003PTC041583. Its GSTIN is 36AADCM6283F1ZD (Telangana). The company holds 25 GST registrations, of which 21 are active.

The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.2 Cr. It was formerly known as Msn Laboratories Limited. It is led by directors including Satyanarayana Reddy Manne (Managing Director) and Laxmi Prasuna Manne.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹7,562.77 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹633.1 Cr (net margin 8.4%) and EBITDA of ₹1,500.91 Cr (EBITDA margin 19.8%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 21% over five years.

The company has about 12,398 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

As per MCA filings, the company has open charges of ₹7,446.49 Cr and satisfied charges of ₹610.63 Cr on record. Court records list 206 cases involving the company, including 85 filed by the company and 121 filed against it; 81 cases are pending. The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹3.2 Cr; the latest was in September 2023. Its 3 peer companies in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Apitoria Pharma Private Limited with revenue of ₹6,811.62 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website msnlabs.com.

Company details

CIN U24239TG2003PTC041583
Registration Number 041583
Incorporation Date 27 August 2003
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

MSN Laboratories has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239TG2003PTC041583, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239TG2003PTC041583Current
U24239AP2003PTC041583Previous
U24239AP2003PLC041583Previous

Recognitions & Rankings of MSN Laboratories

India's Most Valuable Companies 2024 edition · Source: Hurun India
Rank#188
Valuation
₹32,340 Cr
2023 #239 2022 #198 2021 #223

Contact details

MSN Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its website is msnlabs.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Msn House Plot No. C 24 Sanath Nagar Industrial Estate Sanath N, Agar, Hyderabad, Telangana, India – 500018
  • Industry
    Pharma, Drug Formulation & Development, API Manufacturers

To see the full contact details of MSN Laboratories Private Limited, buy the company report.

Comprehensive company report
MSN Laboratories Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of MSN Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of MSN Laboratories Private Limited, buy the company report.

Financials of MSN Laboratories Private Limited

FY 2025 filings available

MSN Laboratories Private Limited reported revenue of ₹7,562.77 Cr (up 12% YoY) for FY 2025.

Revenue · FY 2025
₹7,562.77 Cr ▲ 12%
Net profit · FY 2025
₹633.1 Cr margin 8.4%
EBITDA · FY 2025
₹1,500.91 Cr margin 19.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 22%
5 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 22%
5 years · compounded
▲ 18%

Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 12% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1,500.91 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹633.1 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin19.8%
Net Profit Margin8.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of MSN Laboratories Private Limited, buy the company report.

Board of directors of MSN Laboratories Private Limited

MSN Laboratories has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Laxmi Prasuna ManneDirector27 Aug 200323 Years 2 MonthsCurrent
Bharat Reddy ChintapallyDirector01 Feb 200719 Years 9 MonthsCurrent
Satyanarayana Reddy ManneManaging Director27 Aug 200323 Years 2 MonthsCurrent
Achyuth Reddy ManneDirector27 Jun 20251 Years 4 MonthsCurrent
Sindhuja Reddy ManneDirector27 Jun 20251 Years 4 MonthsCurrent

Peer comparison

MSN Laboratories Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
MSN Laboratories Private Limitedthis company₹7,562.77 Cr (FY 2025)₹633.1 Cr8.4%12.0%12,398Hyderabad, Telangana, India
Apitoria Pharma Private Limited₹6,811.62 Cr (FY 2025)20.0%Hyderabad, Telangana, India
Abbott India Limited₹6,684.73 Cr (FY 2025)10.0%Mumbai, Maharashtra, India
Micro Labs Limited₹6,499.64 Cr (FY 2025)-2.0%Bengaluru, Karnataka, India

To see the full peer comparison of MSN Laboratories Private Limited, buy the company report.

Auditor

MSN Laboratories Private Limited is audited by B.R.M. REDDY AND CO. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
B.R.M. REDDY AND CO.FY 2024003247S

Shareholding

The shareholding of MSN Laboratories Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of MSN Laboratories Private Limited, buy the company report.

Charges & borrowings

Open charges
₹7,446.49 Cr
Satisfied charges
₹610.63 Cr
Breakdown by lending institutions
Others₹2,755.02 Cr
State Bank of India₹1,299.99 Cr
Canara Bank₹1,100.00 Cr
Axis Bank Limited₹648.20 Cr
Hdfc Bank Limited₹635.00 Cr
Others₹1,008.28 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
22 Sep 2026101407571Canara Bank₹500 CrOpen
27 Aug 2026101410964Axis Bank Limited₹30 LakhOpen
05 Aug 2026101359668Axis Bank Limited₹30 LakhOpen
28 Jul 2026101357338Others₹100 CrOpen
14 Jul 2026101338112Axis Bank Limited₹30.32 LakhOpen

To see the full charge records of MSN Laboratories Private Limited, buy the company report.

Total charge records: 99 View all charges

Deals & funding

MSN Laboratories Private Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹3.2 Cr; the latest was in September 2023.

Total deals
6
Secondary share transfers
4
Funding rounds
2
Disclosed funding
₹3.2 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Sep 2023Secondary share transferUndisclosedBuyer: 3 individuals
Seller: 4 individuals
Mar 2022Secondary share transferUndisclosedBuyer: an individual
Seller: 4 individuals
Mar 2019Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
Jul 2018Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2010Funding round₹1 CrInvestors: 4 individuals

To see the full deal history of MSN Laboratories Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

MSN Laboratories Private Limited was last rated by Crisil on 26 Nov 2020.

Rating agencyRated onRating
Crisil26 Nov 2020

To see the full credit ratings and regulatory alerts of MSN Laboratories Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for MSN Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

MSN Laboratories has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Cramsn Research Park Private LimitedU24305TG2022PTC162473

To see the full group structure of MSN Laboratories Private Limited, buy the company report.

Employees & EPFO

MSN Laboratories Private Limited has a workforce of 12,398 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
12,398
Active EPFO establishments
1
Employee growth
21%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2712,398
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of MSN Laboratories Private Limited, buy the company report.

GST

MSN Laboratories has 25 GST registrations: 21 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
25
Active
21
Cancelled / inactive
4
GSTINStateStatusRegistered on
36AADCM6283F1ZDTelanganaActive01 Jul 2017
05AADCM6283F1ZIUttarakhandActive01 Jul 2017
07AADCM6283F1ZEDelhiActive01 Jul 2017
08AADCM6283F1ZCRajasthanActive01 Jul 2017

To see the full GST registrations and return filing status of MSN Laboratories Private Limited, buy the company report.

Recent activity

MSN Laboratories Private Limited has 6 board changes on record since 2003: 6 appointments. The latest: Achyuth Reddy Manne was appointed as Director on 27 Jun 2025.

Charges
A charge with Canara Bank amounted to Rs. 500.00 Cr with Charge ID 101407571 was registered on 22 Sep 2026.
Charges
A charge registered on 18 Aug 2022 via Charge ID 100605906 with Others was fully satisfied on 18 Sep 2026.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.30 Cr with Charge ID 101410964 was registered on 27 Aug 2026.
Charges
A charge registered on 26 Jul 2023 via Charge ID 100754838 with Axis Bank Limited was fully satisfied on 27 Aug 2026.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.30 Cr with Charge ID 101359668 was registered on 05 Aug 2026.
Charges
A charge with Others amounted to Rs. 100.00 Cr with Charge ID 101357338 was registered on 28 Jul 2026.
Charges
A charge with Hdfc Bank Limited of Rs. 635.00 Cr registered on 08 Mar 2019 with Charge ID 100248721 was modified on 22 Jul 2026.
Charges
A charge with Axis Bank Limited of Rs. 420.00 Cr registered on 25 Aug 2004 with Charge ID 90126902 was modified on 22 Jul 2026.
Charges
A charge with Others of Rs. 200.00 Cr registered on 28 Aug 2025 with Charge ID 101151476 was modified on 21 Jul 2026.
Charges
A charge with Others of Rs. 100.00 Cr registered on 30 May 2025 with Charge ID 101104503 was modified on 21 Jul 2026.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.30 Cr with Charge ID 101338112 was registered on 14 Jul 2026.
Charges
A charge with Indian Bank amounted to Rs. 200.00 Cr with Charge ID 101340058 was registered on 10 Jul 2026.

161 earlier events are in the company report.

Frequently asked questions

MSN Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 August 2003 (23+ years old) and is registered under CIN U24239TG2003PTC041583.

MSN Laboratories has 5 current directors:

The latest financial statements of MSN Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of MSN Laboratories is 36AADCM6283F1ZD, registered in Telangana. The company has 25 GST registrations in all, of which 21 are active and 4 are cancelled or inactive. Other active GSTINs include 05AADCM6283F1ZI (Uttarakhand), 07AADCM6283F1ZE (Delhi), 08AADCM6283F1ZC (Rajasthan).

The CIN (Corporate Identification Number) of MSN Laboratories is U24239TG2003PTC041583. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

MSN Laboratories has 206 court cases on record: 85 filed by the company and 121 filed against it. 81 are pending. Most are in the high courts.

MSN Laboratories was incorporated on 27 August 2003, making it 23+ years old. It is registered with the Registrar of Companies, Hyderabad.

MSN Laboratories has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹3.2 Cr; the latest was in September 2023.

The peers of MSN Laboratories by revenue are Apitoria Pharma Private Limited, Abbott India Limited, Micro Labs Limited, all in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Achyuth Reddy Manne was appointed as Director on 27 Jun 2025. Sindhuja Reddy Manne was appointed as Director on 27 Jun 2025. Vinod Kumar Chawla was appointed as Company Secretary on 25 Jul 2012. MSN Laboratories has 6 board changes on record in total.

MSN Laboratories can be reached through the website msnlabs.com. Its registered office is in Hyderabad, Telangana, India.